High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.

Cited by (1,000)

Items 301–400 of 1,000

1. Sodium‐glucose cotransporter‐2 inhibitors and the risk of gout: A Danish population based cohort study and symmetry analysis
   Lars Christian Lund, Mikkel Højlund, Daniel Pilsgaard Henriksen, Jesper Hallas, Kasper Bruun Kristensen · 2021 · Pharmacoepidemiology and Drug Safety
2. Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studies
   David Madigan, Patrick B. Ryan, Martijn J. Schuemie · 2013 · Therapeutic Advances in Drug Safety
3. Treatment Failure and Adverse Events After Amoxicillin-Clavulanate vs Amoxicillin for Pediatric Acute Sinusitis
   Timothy J. Savage, Matthew P. Kronman, Sushama Kattinakere Sreedhara, Su Been Lee, Theresa A. Oduol, Krista F. Huybrechts · 2023 · JAMA
4. Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study
   Edouard L. Fu, Rishi J. Desai, Julie M. Paik, Dae Hyun Kim, Yichi Zhang, Julianna M. Mastrorilli, Alexander Cervone, Kueiyu Joshua Lin · 2023 · American Journal of Kidney Diseases
5. Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data
   Sonja Alsemgeest Swanson, Sonia Hernández–Dı́az, Kristin K. Palmsten, Helen Mogun, Mark Olfson, Krista F. Huybrechts · 2015 · Pharmacoepidemiology and Drug Safety
6. Privacy-Maintaining Propensity Score-Based Pooling of Multiple Databases Applied to a Study of Biologics
   Jeremy A. Rassen, Daniel H. Solomon, Jeffrey R. Curtis, Lisa J. Herrinton, Sebastian Schneeweiß · 2010 · Medical Care
7. The Combination of DPP-4 Inhibitors Versus Sulfonylureas with Metformin After Failure of First-line Treatment in the Risk for Major Cardiovascular Events and Death
   Oriana Hoi Yun Yu, Hui Yin, Laurent Azoulay · 2015 · Canadian Journal of Diabetes
8. Urinary incontinence and mortality among older adults residing in care homes
   Javier Damián, Roberto Pastor‐Barriuso, Fernando José García López, Jesús de Pedro‐Cuesta · 2016 · Journal of Advanced Nursing
9. Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study
   Simone Y. Loo, Janie Coulombe, Sophie Dell’Aniello, James M. Brophy, Samy Suissa, Christel Renoux · 2018 · BMJ Open
10. Alpha-Blocker Use and the Risk of Hypotension and Hypotension-Related Clinical Events in Women of Advanced Age
    Swapnil S. Hiremath, Marcel Ruzicka, William Petrcich, Megan K. McCallum, Gregory L. Hundemer, Peter Tanuseputro, Douglas G. Manuel, Kevin D. Burns, Cedric Edwards, Ann L. Bugeja et al. · 2019 · Hypertension
11. Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score–matched Population-based Cohort Study
    Wajd Alkabbani, Arsène Zongo, Jasjeet K. Minhas‐Sandhu, Dean T. Eurich, Baiju R. Shah, Mhd Wasem Alsabbagh, John‐Michael Gamble · 2021 · Canadian Journal of Diabetes
12. Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies
    Khera, Rohan, Schuemie, Martijn J, Lu, Yuan, Ostropolets, Anna, Chen, RuiJun, Hripcsak, George, Ryan, Patrick B, Krumholz, Harlan M, Suchard, Marc A · 2022 · BMJ Open
13. Risk of Serious Falls Associated With Oxybutynin and Tolterodine: A Population Based Study
    Tara Gomes, David Nelson Juurlink, Joanne M.-W. Ho, Sebastian Schneeweiß, Muhammad Mamdani · 2011 · The Journal of Urology
14. Influence of healthy candidate bias in assessing clinical effectiveness for implantable cardioverter-defibrillators: cohort study of older patients with heart failure
    Soko Setoguchi, Lynne Warner Stevenson, G. C. Stewart, Deepak L. Bhatt, Andrew E. Epstein, Manisha Desai, L. A. Williams, Cheng‐Yu Chen · 2014 · BMJ
15. Association between Use of Exogenous Testosterone Therapy and Risk of Venous Thrombotic Events among Exogenous Testosterone Treated and Untreated Men with Hypogonadism
    Hu Li, Karin Benoit, Wei Wang, Stephen Paul Motsko · 2015 · The Journal of Urology
16. Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis
    Wan‐Ju Lee, Todd A. Lee, Katie J. Suda, Gregory Sampang Calip, Leslie A. Briars, Glen T. Schumock · 2017 · Rheumatology
17. Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study
    Nick Daneman, Dan G. Chateau, Matthew E. Dahl, J. Zhang, Anat Fisher, INGRID S. SKETRIS, Jacqueline M. Quail, Fawziah Marra, Pierre Ernst, Shawn Bugden · 2019 · Clinical Microbiology and Infection
18. Value-Based Care for Musculoskeletal Pain: Are Physical Therapists Ready to Deliver?
    Trevor A. Lentz, Adam P. Goode, Charles A. Thigpen, Steven Z. George · 2019 · Physical Therapy
19. Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada
    Micah Piske, Trevor J. Thomson, Emanuel Krebs, Natt Hongdilokkul, Julie Bruneau, Sander Greenland, Paul Gustafson, Mohammad Ehsanul Karim, Lawrence C. McCandless, Malcolm Maclure et al. · 2020 · BMJ Open
20. Metformin versus sulphonylureas for new onset atrial fibrillation and stroke in type 2 diabetes mellitus: a population-based study
    Jiandong Zhou, Guoming Zhang, Carlin Chang, Oscar Hou In Chou, Sharen Lee, Keith Sai Kit Leung, Wing Tak Wong, Tong Liu, Abraham Ka Chung Wai, Shuk Han Cheng et al. · 2022 · Acta Diabetologica
21. Variable Selection for Confounder Control, Flexible Modeling and Collaborative Targeted Minimum Loss-Based Estimation in Causal Inference
    Mireille E. Schnitzer, Judith J. Lok, Susan Gruber · 2015 · The International Journal of Biostatistics
22. Benchmarking Framework for Performance-Evaluation of Causal Inference Analysis
    Yishai Shimoni, Chen Yanover, Ehud Karavani, Yaara Goldschmnidt · 2018 · arXiv (Cornell University)
23. Field-wide meta-analyses of observational associations can map selective availability of risk factors and the impact of model specifications
    Stylianos Serghiou, Chirag J. Patel, Yan Yu Tan, Peter Koay, John P. A. Ioannidis · 2015 · Journal of Clinical Epidemiology
24. Comparative effectiveness and safety of single inhaler triple therapies for chronic obstructive pulmonary disease: new user cohort study
    William B. Feldman, Samy Suissa, Aaron Seth Kesselheim, Jerry Avorn, Massimiliano Russo, Sebastian Schneeweiß, Shirley V. Wang · 2024 · BMJ
25. Sentinel Modular Program for Propensity Score–Matched Cohort Analyses
    Meijia Zhou, Shirley V. Wang, Charles E. Leonard, Joshua J. Gagne, Candace C. Fuller, Christian Hampp, Patrick Archdeacon, Sengwee Toh, Aarthi Iyer, Tiffany Siu Woodworth et al. · 2017 · Epidemiology
26. Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics
    Charles E. Leonard, Colleen M Brensinger, Warren B. Bilker, Stephen E. Kimmel, Xu Han, Young Hee Nam, Joshua J. Gagne, Margaret J. Mangaali, Sean Hennessy · 2016 · International Journal of Cardiology
27. Comparison of Low-, Moderate-, and High-Molecular-Weight Hyaluronic Acid Injections in Delaying Time to Knee Surgery
    Anand R. Shewale, Charles Lowry Barnes, Lori Ann Fischbach, Songthip Ounpraseuth, Jacob T. Painter, Bradley C. Martin · 2017 · The Journal of Arthroplasty
28. Risk of preterm delivery and small-for-gestational-age births in women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study
    Nicole Tsao, Eric C. Sayre, Gillian E. Hanley, Mohsen Sadatsafavi, Larry David Lynd, Carlo A. Marra, Mary A. De Vera · 2018 · Annals of the Rheumatic Diseases
29. When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?
    Jessica Myers Franklin, Richard G. Platt, Nancy A Dreyer, Alex John London, Gregory E. Simon, Jonathan Hirohiko Watanabe, Michael Alan Horberg, Adrian F. Hernandez, Robert M. Califf · 2021 · Clinical Pharmacology & Therapeutics
30. Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort
    Colin R. Dormuth, Brandace Winquist, Anat Fisher, Fangyun Wu, Pauline Reynier, Samy Suissa, Matthew E. Dahl, Zhihai Ma, Xinya Lu, Jianguo Zhang et al. · 2021 · JAMA Network Open
31. Adherence to Treatment by Initial Antihypertensive Mono and Combination Therapies
    Federico Rea, Laura Savaré, Matteo Franchi, Giovanni Corrao, Giuseppe Mancia · 2021 · American Journal of Hypertension
32. Adjusting for selection bias due to missing data in electronic health records-based research
    Sarah B. Peskoe, David E Arterburn, Karen J. Coleman, Lisa J. Herrinton, Michael J. Daniels, Sebastien Haneuse · 2021 · Statistical Methods in Medical Research
33. Hospital Variation in Nitric Oxide Use for Premature Infants
    Michael Stenger, Jonathan L. Slaughter, Kelly J. Kelleher, Edward G. Shepherd, Mark A. Klebanoff, Patricia B. Reagan, Leif Daniel Nelin, William P Gardner · 2012 · PEDIATRICS
34. Model Averaged Double Robust Estimation
    Matthew S. Cefalu, Francesca Dominici, Nils D. Arvold, Giovanni Parmigiani · 2016 · Biometrics
35. Treatment Dynamics of Newly Marketed Drugs and Implications for Comparative Effectiveness Research
    Joshua J. Gagne, Katsiaryna Bykov, Richard J. Willke, Kristijan H. Kahler, Prasun Subedi, Sebastian Schneeweiß · 2013 · Value in Health
36. Comparison of Long-term Care in Nursing Homes Versus Home Health: Costs and Outcomes in Alabama
    Justin L. Blackburn, Julie L. Locher, Meredith L. Kilgore · 2014 · The Gerontologist
37. Improving therapeutic effectiveness and safety through big healthcare data
    Sebastian Schneeweiß · 2015 · Clinical Pharmacology & Therapeutics
38. Bayesian Methods in Pharmacovigilance*
    David Madigan, Patrick B. Ryan, Shawn Simpson, Ivan Zorych · 2011 · Oxford University Press eBooks
39. Impact of anticoagulant choice on hospitalized bleeding risk when treating cancer‐associated venous thromboembolism
    Neil A. Zakai, Robert F. Walker, Richard F. MacLehose, Terrance J Adam, Álvaro Alonso, Pamela L. Lutsey · 2018 · Journal of Thrombosis and Haemostasis
40. Validity of Privacy-Protecting Analytical Methods That Use Only Aggregate-Level Information to Conduct Multivariable-Adjusted Analysis in Distributed Data Networks
    Xiaojuan Li, BRUCE H. FIREMAN, Jeffrey R. Curtis, David E Arterburn, David P. Fisher, Érick Moyneur, Mia Gallagher, Marsha A. Raebel, W. Benjamin Nowell, Lindsay Lagreid et al. · 2018 · American Journal of Epidemiology
41. Comparing medication persistence among patients with type 2 diabetes using sodium-glucose cotransporter 2 inhibitors or glucagon-like peptide-1 receptor agonists in real-world setting
    Federico Rea, Stefano Ciardullo, Laura Savaré, Gianluca Perseghin, Giovanni Corrao · 2021 · Diabetes Research and Clinical Practice
42. Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics
    Leonard Ce, WB Bilker, Colleen M Brensinger, Xiaopeng Han, James Flory, David Alastair Flockhart, JJ Gagne, Serena Cardillo, Sean Hennessy · 2015 · Clinical Pharmacology & Therapeutics
43. Interpretable machine learning in predicting drug-induced liver injury among tuberculosis patients: model development and validation study
    Yue Xiao, Yanfei Chen, Ruijian Huang, Feng Jiang, Jifang Zhou, Tianchi Yang · 2024 · BMC Medical Research Methodology
44. Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems
    Lisa J. Herrinton, Jeffrey R. Curtis, Lang Chen, Liyan Liu, Elizabeth Delzell, James D. Lewis, Daniel H. Solomon, Marie R. Griffin, Rita Ouellet‐Hellstrom, Timothy Beukelman et al. · 2011 · Pharmacoepidemiology and Drug Safety
45. Comparative cardiovascular safety of glucagon‐like peptide‐1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study
    Elisabetta Patorno, Brendan M. Everett, Allison B. Goldfine, Robert J. Glynn, J. Liu, Chandrasekar Gopalakrishnan, S. C. Kim · 2016 · Diabetes Obesity and Metabolism
46. Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia
    Charles E. Leonard, Colleen M Brensinger, Christina L. Aquilante, Warren B. Bilker, Denise M. Boudreau, Rajat Deo, James Flory, Joshua J. Gagne, Margaret J. Mangaali, Sean Hennessy · 2018 · Diabetes Care
47. Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure
    Chih-Ying Chen, Lynne Warner Stevenson, Garrick C. Stewart, Deepak L. Bhatt, Manisha Desai, John D. Seeger, Lauren A. Williams, Jessica J. Jalbert, Soko Setoguchi · 2015 · BMJ
48. Active Safety Monitoring of New Medical Products Using Electronic Healthcare Data
    Joshua J. Gagne, Jeremy A. Rassen, Alexander Muir Walker, Robert J. Glynn, Sebastian Schneeweiß · 2012 · Epidemiology
49. Autologous platelet rich fibrin glue for sealing of low-output enterocutaneous fistulas: An observational cohort study
    Xiuwen Wu, Jianan Ren, Guosheng Gu, Gefei Wang, Gang Han, Bo Zhou, Huajian Ren, Min Yao, Vickie R. Driver, Jieshou Li · 2013 · Surgery
50. Risk of discontinuation of antipsychotic long‐acting injections vs. oral antipsychotics in real‐life prescribing practice: a community‐based study
    Hélène Verdoux, Élodie Pambrun, Marie Tournier, Julien Bezin, A. Pariente · 2017 · Acta Psychiatrica Scandinavica
51. The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: A cohort study
    John‐Michael Gamble, Jennifer R. Donnan, Eugene Chibrikov, Laurie Twells, William K. Midodzi, Sumit R. Majumdar · 2017 · Diabetes Research and Clinical Practice
52. How Did the COVID-19 Crisis Affect Different Types of Workers in the Developing World?
    Maurice D. Kugler, Mariana Viollaz, Daniel Duque, Isis Gaddis, David Newhouse, Amparo Palacios-López, Michael Weber · 2021 · World Bank policy research working paper
53. Sparse conditional logistic regression for analyzing large-scale matched data from epidemiological studies: a simple algorithm
    Marta Avalos, Hélène Pouyes, Yves Grandvalet, Ludivine Orriols, Emmanuel Lagarde · 2015 · BMC Bioinformatics
54. Is Size the Next Big Thing in Epidemiology?
    Sengwee Toh, Richard G. Platt · 2013 · Epidemiology
55. Risk of gastrointestinal bleeding and cardiovascular events due to NSAIDs in the diabetic elderly population
    Jung-Mee Kim, Joongyub Lee, Cheol Min Shin, Dong Ho Lee, Byung‐Joo Park · 2015 · BMJ Open Diabetes Research & Care
56. Antidepressants and the risk of death in older patients with depression: A population-based cohort study
    Bianca Kollhorst, Kathrin Jobski, Jutta Krappweis, Tania Schink, Edeltraut Garbe, Niklas Schmedt · 2019 · PLoS ONE
57. Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer ~propensity score- matched analysis~
    Hiroaki Kajiyama, Shiro Suzuki, Nobuhisa Yoshikawa, Michiyasu Kawai, Kimio Mizuno, Osamu Yamamuro, Tetsuro Nagasaka, Kiyosumi Shibata, Fumitaka Kikkawa · 2019 · BMC Cancer
58. Comparative effectiveness of gliclazide modified release versus sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes
    Francesco Zaccardi, Emmanuelle Jacquot, Viviana Cortese, Freya Tyrer, Samuel Seidu, Melanie Jane Davies, Kamlesh Khunti · 2020 · Diabetes Obesity and Metabolism
59. Real‐world evidence of bariatric surgery and cardiovascular benefits using electronic health records data: A lesson in bias
    Jeremy A. Rassen, William K. Murk, Sebastian Schneeweiß · 2021 · Diabetes Obesity and Metabolism
60. Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
    Edward Chia‐Cheng Lai, Tzu‐Chieh Lin, Jeffrey L. Lange, L. Chen, Ian Chi Kei Wong, Chor‐Wing Sing, Ching‐Lung Cheung, Shih‐Chieh Shao, Yea Huei Kao Yang · 2022 · Osteoporosis International
61. Sodium–glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study
    Edouard L. Fu, Elisabetta Patorno, Brendan M. Everett, Muthiah Vaduganathan, Scott David Solomon, Raisa Levin, Sebastian Schneeweiß, Rishi J. Desai · 2023 · European Heart Journal
62. Targeted Maximum Likelihood Estimation for Pharmacoepidemiologic Research
    Menglan Pang, Tibor Schuster, Kristian B. Filion, María Eberg, Robert William Platt · 2016 · Epidemiology
63. Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents
    Jenny W. Sun, Sonia Hernández–Dı́az, Sebastien Haneuse, Florence T. Bourgeois, Seanna M. Vine, Mark Olfson, Brian T. Bateman, Krista F. Huybrechts · 2020 · JAMA Psychiatry
64. Centralized and Federated Models for the Analysis of Clinical Data
    Ruowang Li, Joseph D. Romano, Yong Chen, Jason H. Moore · 2024 · Annual Review of Biomedical Data Science
65. Comparative Effectiveness of Carotid Artery Stenting Versus Carotid Endarterectomy Among Medicare Beneficiaries
    Jessica J. Jalbert, Louis L. Nguyen, Marie Denise Gerhard‐Herman, Hiraku Kumamaru, Chih-Ying Chen, Lauren A. Williams, Jun Liu, Andrew T. Rothman, Michael R. Jaff, John D. Seeger et al. · 2016 · Circulation Cardiovascular Quality and Outcomes
66. Prenatal antibiotic exposure and risk of attention-deficit/hyperactivity disorder: a population-based cohort study
    Amani F. Hamad, Silvia Alessi‐Severini, Salaheddin M. Mahmud, Marni D Brownell, I fan Kuo · 2020 · Canadian Medical Association Journal
67. A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients
    Gang Li, Ling Zhang, Allitia DiBernardo, Grace Wang, John J. Sheehan, Kwan Lee, Johan Reutfors, Qiaoyi Zhang · 2020 · PLoS ONE
68. Proton pump inhibitors and risk of all‐cause and cause‐specific mortality: A cohort study
    Jeremy Philip Brown, John Tazare, Elizabeth Williamson, Kathryn Elizabeth Mansfield, Stephen J. W. Evans, Laurie A. Tomlinson, Krishnan Bhaskaran, Liam L Smeeth, Kevin Wing, Ian Douglas · 2021 · British Journal of Clinical Pharmacology
69. Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada
    Cerina Lee, Mu Lin, Karen J. B. Martins, Jason R.B. Dyck, Scott W Klarenbach, Lawrence P. Richer, Ed Jess, John G. Hanlon, Elaine Hyshka, Dean T. Eurich · 2021 · BMC Public Health
70. Comparison of Clinical Outcomes and Safety Associated With Chlorthalidone vs Hydrochlorothiazide in Older Adults With Varying Levels of Kidney Function
    Cedric Edwards, Gregory L. Hundemer, William Petrcich, Mark Canney, Greg A. Knoll, Kevin D. Burns, Ann L. Bugeja, Manish M. Sood · 2021 · JAMA Network Open
71. External control arm analysis: an evaluation of propensity score approaches, G-computation, and doubly debiased machine learning
    Nicolas Loiseau, Paul Trichelair, Maxime He, Mathieu Andreux, Mikhail Zaslavskiy, Gilles Wainrib, Michaël G. B. Blum · 2022 · BMC Medical Research Methodology
72. A modular, prospective, semi‐automated drug safety monitoring system for use in a distributed data environment
    Joshua J. Gagne, Shirley V. Wang, Jeremy A. Rassen, Sebastian Schneeweiß · 2014 · Pharmacoepidemiology and Drug Safety
73. Addressing Limitations in Observational Studies of the Association Between Glucose-Lowering Medications and All-Cause Mortality: A Review
    Elisabetta Patorno, Elizabeth M. Garry, Amanda R. Patrick, Sebastian Schneeweiß, Victoria G. Gillet, Olesya Zorina, Dorothee B. Bartels, John D. Seeger · 2015 · Drug Safety
74. Potential Health Care Cost Savings Associated With Early Treatment of Multiple Sclerosis Using Disease-Modifying Therapy
    Suellen M. Curkendall, Cheng Wang, Barbara H. Johnson, Zhun Cao, Ronald Preblick, Amelito Torres, Volker A. Knappertz, Kathleen Gondek · 2011 · Clinical Therapeutics
75. Impact of point-of-care ultrasonography on ED time to disposition for patients with nontraumatic shock
    Michael Kennedy Hall, Richard Andrew Taylor, Seth Luty, I. Elaine Allen, Chris Moore · 2016 · The American Journal of Emergency Medicine
76. Optimal Use of Available Claims to Identify a Medicare Population Free of Coronary Heart Disease
    Shia T. Kent, Monika M. Safford, Hong Zhao, Emily B. Levitan, Jeffrey R. Curtis, Ryan D. Kilpatrick, Meredith L. Kilgore, Paul Muntner · 2015 · American Journal of Epidemiology
77. A Case Study of the Impact of Data-Adaptive Versus Model-Based Estimation of the Propensity Scores on Causal Inferences from Three Inverse Probability Weighting Estimators
    Romain S. Neugebauer, Julie A. Schmittdiel, Mark J. van der Laan · 2016 · The International Journal of Biostatistics
78. Chasing Balance and Other Recommendations for Improving Nonparametric Propensity Score Models
    Beth Ann Griffin, Daniel F. McCaffrey, Daniel Almirall, Lane F. Burgette, Claude Messan Setodji · 2017 · Journal of Causal Inference
79. First Trimester Use of Buprenorphine or Methadone and the Risk of Congenital Malformations
    Elizabeth A. Suarez, Brian T. Bateman, Loreen Straub, Sonia Hernández–Dı́az, Hendrée E. Jones, Kathryn J. Gray, Hilary Smith Connery, Jonathan M. Davis, Barry M. Lester, Mishka Terplan et al. · 2024 · JAMA Internal Medicine
80. Impact of maternal characteristics on the effect of maternal influenza vaccination on fetal outcomes
    Demilade A. Adedinsewo, Laila Noory, Robert A. Bednarczyk, Mark C. Steinhoff, Robert Lowell Davis, Chinelo A. Ogbuanu, Saad B. Omer · 2013 · Vaccine
81. Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high‐risk population
    David Nelson Juurlink, Tara Gomes, Baiju R. Shah, Muhammad Mamdani · 2012 · Diabetic Medicine
82. Controlling confounding of treatment effects in administrative data in the presence of time‐varying baseline confounders
    David T. Gilbertson, Brian D. Bradbury, James B. Wetmore, Eric D. Weinhandl, Keri L. Monda, Jiannong Liu, M. Alan Brookhart, Sally K. Gustafson, Tricia L. Roberts, Allan J. Collins et al. · 2015 · Pharmacoepidemiology and Drug Safety
83. Safe Expectations: Current State and Future Directions for Medication Safety in Pregnancy Research
    Mollie E. Wood, Susan E. Andrade, Sengwee Toh · 2019 · Clinical Therapeutics
84. Comparative Effectiveness and Safety of Oral Anticoagulants by Dementia Status in Older Patients With Atrial Fibrillation
    Kueiyu Joshua Lin, Daniel E. Singer, Katsiaryna Bykov, Lily Gui Bessette, Julianna M. Mastrorilli, Alexander Cervone, Dae Hyun Kim · 2023 · JAMA Network Open
85. The effect of labour induction on the risk of caesarean delivery: using propensity scores to control confounding by indication
    Valery A. Danilack, David D. Dore, E.W. Triche, Janet H. Muri, MG Phipps, D A Savitz · 2015 · BJOG An International Journal of Obstetrics & Gynaecology
86. Comparison of high-dimensional confounder summary scores in comparative studies of newly marketed medications
    Hiraku Kumamaru, Joshua J. Gagne, Robert J. Glynn, Soko Setoguchi, Sebastian Schneeweiß · 2016 · Journal of Clinical Epidemiology
87. Sodium‐glucose co‐transporter 2 inhibitors and the risk of fractures: A propensity score‐matched cohort study
    Sruthi Adimadhyam, Todd A. Lee, Gregory Sampang Calip, Daphne E. Smith Marsh, Brian Thomas Layden, Glen T. Schumock · 2019 · Pharmacoepidemiology and Drug Safety
88. Deep Learning-based Propensity Scores for Confounding Control in Comparative Effectiveness Research
    Janick G. Weberpals, Tim Becker, Jessica Davies, Fabian Schmich, Dominik Rüttinger, Fabian Joachim Theis, Anna Bauer‐Mehren · 2021 · Epidemiology
89. Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study
    Phyo Than Htoo, Helen Tesfaye, Sebastian Schneeweiß, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz‐Luyet, Julie M. Paik et al. · 2024 · Cardiovascular Diabetology
90. The U.S. Food and Drug Administration's Mini‐Sentinel Program
    Richard G. Platt, Ryan M. Carnahan · 2012 · Pharmacoepidemiology and Drug Safety
91. Dimension reduction and shrinkage methods for high dimensional disease risk scores in historical data
    Hiraku Kumamaru, Sebastian Schneeweiß, Robert J. Glynn, Soko Setoguchi, Joshua J. Gagne · 2016 · Emerging Themes in Epidemiology
92. Challenges in IBD Research: Pragmatic Clinical Research
    Frank I. Scott, David T. Rubin, Subra Kugathasan, Athos Bousvaros, Charles O. Elson, Rodney D. Newberry, Gil Melmed, Joel R. Pekow, James W. Fleshman, Brendan M. Boyle et al. · 2019 · Inflammatory Bowel Diseases
93. Robust inference on the average treatment effect using the outcome highly adaptive lasso
    Cheng Ju, David C. Benkeser, Mark J. van der Laan · 2019 · Biometrics
94. The association of beta-blocker use with mortality in elderly patients with congestive heart failure and advanced chronic kidney disease
    Amber O. Molnar, William Petrcich, Matthew A. Weir, Amit X. Garg, Michael W. Walsh, Manish M. Sood · 2019 · Nephrology Dialysis Transplantation
95. Comparing high-dimensional confounder control methods for rapid cohort studies from electronic health records
    Yen Low, Blanca Gallego, Nigam Haresh Shah · 2015 · Journal of Comparative Effectiveness Research
96. US Government Claims Databases
    Sean Hennessy, Cristin Palumbo Freeman, Francesca E. Cunningham · 2012 · Pharmacoepidemiology
97. Methodological Tutorial Series for Epidemiological Studies: Confounder Selection and Sensitivity Analyses to Unmeasured Confounding From Epidemiological and Statistical Perspectives
    Kosuke Inoue, Kentaro Sakamaki, Sho Komukai, Yuri Ito, Atsushi Goto, Tomohiro Shinozaki · 2024 · Journal of Epidemiology
98. Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort Study
    Daniel R. Morales, Fan Bu, Benjamin Viernes, Scott L. DuVall, Michael Edwin Matheny, Katherine Simon, Thomas Falconer, Lauren R. Richter, Anna Ostropolets, Wallis C. Y. Lau et al. · 2025 · Diabetes Care
99. Comparative risk of death in older adults treated with antipsychotics: A population-based cohort study
    Niklas Schmedt, Bianca Kollhorst, Dirk Enders, Kathrin Jobski, Jutta Krappweis, Edeltraut Garbe, Tania Schink · 2016 · European Neuropsychopharmacology
100. Comparing the high-dimensional propensity score for use with administrative data with propensity scores derived from high-quality clinical data
     Peter C. Austin, C Fangyun Wu, Douglas S. Lee, Jack V. Tu · 2019 · Statistical Methods in Medical Research